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Abstract Facioscapulohumeral muscular dystrophy (FSHD) is
an autosomal dominant myopathy associated with deletions of a
subtelomeric repeat (D4Z4). A reduction in D4Z4 copy number
coincides with increased expression of neighboring 4q35 genes,
implying a normal repressive role for the repeats. Here we ex-
amine the e¡ect of increasing D4Z4 repeat number on reporter
gene activity in C2C12 cells. Repeat size had only a minor cis-
e¡ect on reporter gene activity but greatly compromised myo-
tube formation. This latter trans-e¡ect did not result from ex-
pression of a gene within the repeat (DUX4) but likely results
from squelching of the D4Z4 recognition complex.
0 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Facioscapulohumeral muscular dystrophy (FSHD), an au-
tosomal dominant disorder with an incidence of 1 in 20 000, is
characterized by facial and shoulder girdle muscle atrophy
that often progresses to include muscles of the lower limb
[1,2]. Genetic studies localized the FSHD gene to the subtelo-
meric region of chromosome 4 [3,4]. Molecular characteriza-
tion of this region demonstrated that both familial and spo-
radic FSHD were associated with deletion of several copies of
a 3.3 kb tandem repeat at 4q35, termed D4Z4 [5,6].
Each copy of the D4Z4 repeat contains several repetitive
elements common to heterochromatin and an open reading
frame encompassing a double homeodomain sequence motif,
now called DUX4 [7,8]. However, the inability to identify a
functional DUX4 transcript encouraged a position^e¡ect hy-
pothesis as the disease mechanism. As such, a reduced D4Z4
array would in£uence the expression of neighboring genes
either by silencing, as a result of increased proximity to the
telomere or, through inappropriate activation provided the
D4Z4 repeats normally function as long-range repressors
[7,9]. The region immediately proximal to the D4Z4 repeats
then became a focal point for the identi¢cation of genes that
may be subject to position e¡ects. Sequence analysis demon-
strated that the proximal 400 kb interval is relatively gene
poor with a tubulin pseudogene (TUB4Q) and the FRG1
(FSHD region gene 1) gene residing closest to the repeats
[10,11]. Also within 4q35 lie several attractive candidate genes
encoding muscle-enriched transcripts (e.g. ALP, ANT1), yet
none have proven to be causative of the disease [12^15].
A single nucleotide polymorphism was used to demonstrate
that FRG1 expression from a D4Z4-deleted chromosome was
slightly increased over the normal allele of an FSHD patient
[11]. This suggested that a reduction in D4Z4 repeats relieves
repression from nearby genes. Indeed, FRG1, FRG2 and
ANT1 RNA levels were upregulated in FSHD muscle and
this was correlated with decreasing repeat length [16]. More-
over, a 27 bp element (DBE) identi¢ed within the D4Z4 re-
peat was shown to be repressive when multiple copies were
placed between a promoter and the corresponding reporter
gene [16]. Further studies characterized the protein complex
that binds to the DBE, named the D4Z4 recognition complex
(DRC), comprising the proteins YY1, HMGB2, and nucleolin
[16].
In this study, we used increasing copies of the D4Z4 repeats
positioned directly upstream of a LacZ construct to determine
the e¡ect on reporter gene activity and muscle di¡erentiation
following transfection into C2C12 myoblasts. We demonstrate
that increasing D4Z4 repeats have a signi¢cant trans-e¡ect on
myoblast di¡erentiation with only a minor cis-e¡ect on re-
porter gene activity.
2. Materials and methods
2.1. Generation of DNA constructs
D4Z4 repeats (3.3 kb) were excised by KpnI digestion from cosmid
cY13 [17]. Isolated repeats were concatamerized and ligated into
pBluescript II KS (Stratagene, La Jolla, CA, USA) and sequenced
for con¢rmation. Arrays containing one to four copies were cloned
93 bp upstream of the BOS-LacZ reporter of pRP2044 (gift of
R. Parks, Ottawa, ON, Canada) to generate pDY01-pDY04 [18].
2.2. Cell culture, transfection and reporter assays
C2C12 myoblasts and stable clones were maintained as described
[19]. Cells (2U105 cells/3 cm dish) were transiently transfected with
equal molar ratios of plasmid using Lipofectamine Reagent (Invitro-
gen). After 48 h, replicate plates were either harvested for analysis,
assayed for transfection e⁄ciency using L-gal in situ analysis [20], or
induced to di¡erentiate by mitogen deprivation [21]. To establish sta-
ble clones, C2C12 cells were co-transfected with the neomycin selec-
tion plasmid pGTNeo (New England Biolabs) and grown in 0.8 mg/
ml G418 (Invitrogen).
Positive clones were identi¢ed by PCR [50 Wl reaction; 30 cycles of
94‡C (30 s); 56‡C (30 s); 72‡C (60 s)] using primers for D4Z4 or LacZ
(primer sequences listed in Section 2.4). Transgene copy number and
insertion sites were determined by Southern analysis using a 2.3 kb
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NdeI/NheI fragment of LacZ as a probe [22]. A fragment of the mouse
Snf2h gene served as a loading control [23].
Cell lysates were prepared using Reporter Lysis Bu¡er (Promega,
Madison, WI, USA). Following protein quanti¢cation (DC Protein
Assay, Bio-Rad, Hercules, CA, USA),V5 ng was used to assess L-gal
activity with the o-nitrophenyl-L-D-galactopyranoside assay [18].
2.3. Immunocytochemistry and analysis of myotube fusion
Cells were stained with a monoclonal MF20 anti-myosin antibody
(Developmental Studies Hybridoma Bank), detected using a goat anti-
mouse IgG conjugated to horseradish peroxidase (Invitrogen), and
counter stained with Harris modi¢ed Hematoxylin. Fusion compe-
tence was determined after 4 days of di¡erentiation using the Myo-
tube Fusion Index (MFI) following assessment of 20 ¢elds from each
of four to six plates [24]. The Deformed Myotube Index (DMI) was
calculated as the proportion of myotubes with a deformed morphol-
ogy and was determined similarly to the MFI.
2.4. RNA isolation and RT-PCR analysis
RNA was isolated from cells during growth or following di¡eren-
tiation by the guanidinium method [25]; 5 Wg was reverse transcribed
using Superscript RT (Invitrogen) and random hexamers (Invitrogen).
PCR was for 30 cycles [94‡C (30 s); 56‡C (52‡C for D4Z4; 30 s); 72‡C
(60 s)] using primers for D4Z4 (D4Z4f1905 ^ 5P-cgagcctgctttgaccg-3P ;
D4Z4r2385 ^ 5P-cgtggggtgcgggag-3P), LacZ (ras39 ^ 5P-ttggcctgaactgc-
cagctggcgcagg-3P ; ras40 ^ 5P-tcccgcagcgcagaccgttttcgctcg-3P), or L-ac-
tin (Ambion Inc.).
3. Results and discussion
To assess the silencing e¡ect of D4Z4 repeats on reporter
gene expression we generated plasmids containing one to four
D4Z4 copies upstream of the BOS (EF1K) promoter and the
LacZ reporter gene (Fig. 1A,B). The parental plasmid,
pRP2044, which lacks D4Z4 served as a control. Plasmids
were transient transfected into C2C12 myoblasts and analyzed
for L-gal activity during growth conditions, or following myo-
blast di¡erentiation. During growth we observed no statistical
di¡erences in reporter activity between the control and exper-
imental plasmids pDY01, pDY02, and pDY04 (Fig. 1C).
There was an increase in reporter activity between pDY03
and the control (P=0.018), yet the signi¢cance of this result
remains to be determined. Since we anticipated that D4Z4
would inhibit LacZ expression, these results suggested that
repression might be speci¢c to di¡erentiating myoblasts. As
such, transfected cells were cultured in di¡erentiation media
and then assessed for L-gal activity over a period of 96 h (Fig.
1D). We observed an initial decrease in L-gal activity for all
samples at 12 h, coinciding with signi¢cant apoptosis, a com-
mon response to the stress of mitogen deprivation [24,26]. The
control sample regained basal L-gal levels within 24 h (dark
bars). Cells transfected with pDY02 and pDY04 (white and
gray bars, respectively) appeared to demonstrate a lag in re-
covery but this was not statistically signi¢cant. However, L-gal
activity was mildly compromised at 96 h for cells transfected
with pDY04 (P=0.001), suggesting that the repeats may sub-
tly impede gene expression during di¡erentiation. The subtle
e¡ects may be a re£ection of the number of D4Z4 repeats
contained within the constructs. Patient studies suggest there
is a threshold number of repeats (s 10) below which a phe-
Fig. 1. D4Z4 repeats have a mild cis-e¡ect on reporter gene activity. (A) Schematic diagram of pRP2044 and pDY01-pDY04 plasmids.
(B) Agarose gel depicting the D4Z4 repeat array following digestion with HindIII. (C) L-Gal activity during growth normalized to pRP2044
(n=18). No signi¢cant di¡erences in reporter activity were observed for the constructs compared to the control (pRP2044) with the exception
of pDY03 (*P=0.018). (D) L-Gal activity plotted at 0, 12, 24, 48, 72 and 96 h after di¡erentiation (n=3). pRP2044 (black), pDY02 (white)
and pDY04 (gray). After 96 h a signi¢cant decrease in L-gal activity was observed for pDY04 (*P=0.001).
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notype is apparent [27]. In this regard, plasmids containing a
greater number of repeats may be associated with enhanced
reporter silencing.
Nonetheless, an abnormal morphology was apparent in the
transfected cultures undergoing di¡erentiation. Analysis of
muscle di¡erentiation by immunostaining (myosin heavy
chain, MF20; Fig. 2A^D) was normal, suggesting that the
defect was in myoblast fusion. To assess fusion competence
we calculated the MFI, which is the ratio of nuclei present in
myotubes to total nuclei in a ¢eld, where a myotube is de¢ned
as containing three or more nuclei. We observed typical MFI
values of 70% for wild type C2C12 cells, but also noted that
control transfections dropped the MFI to 40% (see Fig. 2E).
Regardless, the D4Z4 constructs (pDY02 and pDY04) further
reduced the MFI to 20% and the myotubes appeared thick
and more rounded with the nuclei localized in the center,
compared to the thin elongated structures of control cultures.
To quantify this phenotype we developed the DMI, which is
the proportion of myotubes in the culture with the abnormal
phenotype. There is a low DMI in wild type C2C12 and
pRP2044 transfected cells (1% and 2.6%, respectively) suggest-
ing that non-D4Z4 plasmids have little e¡ect in the formation
of the deformed structures (Fig. 2F). However, we noted a
very signi¢cant increase in the proportion of deformed myo-
tubes upon pDY02 (6%) or pDY04 (21%) transfection sug-
gesting that the repeats alter normal myotube fusion.
Transient transfections demonstrated that increasing D4Z4
repeat number has an escalating e¡ect on myoblast fusion. To
ensure that this was not an artifact of transfection we gener-
ated stable clones with pRP2044 and pDY04. We postulated
Fig. 2. Myotube fusion and morphology are e¡ected by D4Z4 repeats. Following di¡erentiation, cultures were stained for myosin heavy chain
(MF20); C2C12 myotube cultures (A); pRP2044 (B); pDY02 (C); and pDY04 (D). Arrows denote speci¢c myotubes with deformed morphol-
ogy. Scale bars represent approximately 110 Wm. (E) Plot of mean MFIUS.E.M. for di¡erentiated cultures (n=4; 20 ¢elds analyzed for each
experiment). An asterisk denotes samples of statistical signi¢cance (*P6 0.00001). (F) Plot of the mean DMIUS.E.M. An asterisk denotes sam-
ples of statistical signi¢cance (*P6 0.03).
Table 1
Summary of transgene copy and insertion site number for stable clones
Clone Copy numbera Insertionsa Homogeneity (%)b Growth L-galc Di¡erentiation L-galc
cRP20442 3 ND 95 0.07U0.008 0.02U 0.008
cRP20444 4 ND 100 0.08U0.008 0.06U 0.001
cRP2044n5 2 1 100 0.77U0.130 0.25U 0.068
cRP2044n7 3 1 95 0.36U0.013 0.33U 0.064
cRP2044n15 ND ND 93 0.07U0.002 0.05U 0.014
cRP2044n24 4 1 100 0.35U0.030 0.29U 0.031
cRP2044n31 1 1 100 0.63U0.150 0.28U 0.012
cDY041 1 1 100 0.03U0.006 0.06U 0.025
cDY042 3 ND 90 0.03U0.001 0.05U 0.003
cDY04n2 12 1 95 0.16U0.024 0.05U 0.009
cDY043 2 2 100 0.61U0.190 0.07U 0.014
cDY044 2 2 85 0.02U0.001 0.02U 0.006
cDY04n/3 2 1 100 0.01U0.008 0.02U 0.007
cDY04n/23 1 1 95 0.03U0.002 0.03U 0.004
aCopy and insertion numbers estimated from Southern blot analysis. Refer to Section 2 (data not shown). ND, not determined.
bHomogeneity re£ects the percentage of cells in culture expressing L-gal.
cData is represented as optical density (A420) U standard error of the mean, (n=8).
FEBS 27006 13-2-03 Cyaan Magenta Geel Zwart
D.J. Yip, D.J. Picketts/FEBS Letters 537 (2003) 133^138 135
that multiple insertions at a single integration site might en-
hance the repressive e¡ect we observed in transient experi-
ments simply by increasing repeat copy number or through
repeat-induced heterochromatin formation. Since the neomy-
cin gene can infer a negative e¡ect on a promoter contained
within the same plasmid, we generated stable clones by co-
transfecting pRP2044 or pDY04 with the drug selectable plas-
mid pGTNeo [28]. In this way, we obtained seven clones for
each construct that were characterized for LacZ expression
(homogeneity), the D4Z4 fragment by PCR, and the number
of integrations and transgene copies by Southern blot (Table 1
and data not shown). Each clone was 85^100% homogeneous
for LacZ expressing cells and most clones contained a single
insertion site. As expected, variable transgene copy number
and position e¡ects within our panel of clones contributed
to provide a broad range of LacZ expression under growth
conditions. Since the transient studies suggested that the
D4Z4 repeat would repress reporter activity following di¡er-
entiation, we compared L-gal activity during growth and fol-
lowing di¡erentiation (Table 1). Decreased L-gal was detected
for the D4Z4-clones cDY043 and cDY04n2. However, this
trend was not consistent among all clones. These results dem-
onstrate that position e¡ects are a signi¢cant contributory
factor to reporter gene activity that cannot be overcome by
the presence of D4Z4 repeats.
However, we did observe a consistent defect in normal
myoblast fusion among all clones that contained the D4Z4
repeats (Fig. 3B^D,F). Clones containing the D4Z4 repeat
formed myotubes with a large central mass of nuclei and no
structural uniformity (Fig. 3B^D, arrows). This phenotype
was markedly enhanced from the morphology we observed
for the transient assays. Indeed, DMI calculations showed
an average level of 55% for pDY04 clones (Fig. 3H), whereas
MFI values were similar to transient experiments. Moreover,
cells containing D4Z4 repeats contribute to myotube forma-
tion as shown by in situ L-gal staining (Fig. 3E,F). Di¡er-
entiation was normal as assessed by immunostaining
(MF20) and immunoblot (MyoD, MEF2; data not shown).
Pulse labeling with BrdU during di¡erentiation demonstrated
that the excess nuclei in the deformed myotubes were not
caused by endoreduplication (data not shown). Thus, we con-
clude that, like the transient experiments the stable clones
have a defect in fusion.
The consistent myoblast fusion defect observed between
transient and stable assays suggests that the D4Z4 repeats
might directly cause this impairment. Such a suggestion is
not unprecedented. Sequence analysis of the D4Z4 repeat
identi¢ed a putative gene, DUX4, encoding a double homeo-
domain protein while a subsequent study characterized a pu-
tative DUX4 promoter that could drive reporter gene expres-
sion [8,29]. Taken together, this work suggested that FSHD
patients may re-activate the DUX4 gene when copies are re-
duced below a threshold level [8]. Since a similar mechanism
could explain our results, we designed primers to evaluate
DUX4 gene expression by RT-PCR following di¡erentiation
of the stable clones (Fig. 4A^H). Expression of LacZ was
con¢rmed by ampli¢cation of a 180 bp fragment in all stable
clones but not in control samples (C2C12 or -RT samples).
Fig. 3. Defective di¡erentiation in stable clones is dependent on D4Z4 copy number. Di¡erentiated cultures of stable clones cRP20444 (A),
cDY042 (B), cDY043 (C), cDY04n3 (D), cRP2044n5 (E), and cDY04n2 (F) were stained with the MF20 antibody (A^D), or X-gal (E,F). The
arrows denote speci¢c myotubes with abnormal morphology. Scale bars represent approximately 93 Wm. (G) Stable clones demonstrate a re-
duced MFI compared to wild type C2C12 cells. The mean MFIUS.E.M. is plotted for each clone (n=6; 30 ¢elds analyzed for each experi-
ment). Unincorporated myoblasts from clone cRP2044n5 (denoted by #) displayed an abnormally high level of apoptosis, such that MFI values
were skewed. An asterisk denotes samples of statistical signi¢cance (*P6 1U1038). (H) Plot of the mean DMIUS.E.M. for each stable clone
(n=6; 30 ¢elds analyzed per experiment). An asterisk denotes samples that were statistically signi¢cant (*P6 0.001).
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RNA integrity was demonstrated by the ampli¢cation of L-ac-
tin (300 bp fragment) in all samples. However, we were unable
to amplify the D4Z4-speci¢c sequence (480 bp) from any
clone. This was not the result of primer selection or technical
di⁄culties as genomic DNA was ampli¢ed from the same
clones (Fig. 4I). These results suggest that the e¡ect of
D4Z4 repeats on myotube di¡erentiation is not due to expres-
sion from within the D4Z4 repeat but by some other mecha-
nism.
The results of our study demonstrate that the D4Z4 repeats
a¡ect normal myotube formation, such that increasing the
repeats resulted in a greater percentage of deformed myo-
tubes. This is clearly a trans-e¡ect as we observed minimal
e¡ects in cis on the BOS promoter and LacZ expression.
Similar studies using the C2C12 culture system have been
performed with the myotonic dystrophy protein kinase gene
(DMPK) yet in this instance, the DM mutation had both cis-
and trans-e¡ects on myogenesis [21,30].
The trans-e¡ect in our system is enhanced with increasing
D4Z4 repeat number. This e¡ect is opposite to that observed
in FSHD patients where disease severity is inversely propor-
tional to repeat number. One possible explanation for the
discrepancy between our in vitro ¢ndings and those in patients
is that the repeats may be squelching the DRC complex, thus
allowing for inappropriate expression of genes normally si-
lenced during muscle di¡erentiation. The absence of D4Z4
repeats in the mouse genome [31] suggests that muscle-speci¢c
silencing of FRG1, FRG2, and ANT1 genes by the DRC
complex occurs through promoter-speci¢c elements. Thus,
the presence of ectopic D4Z4 repeats in our C2C12 system
Fig. 4. Di¡erentiation defects do not result from expression of D4Z4-speci¢c sequences. Primers speci¢c to amplify the D4Z4 repeat (480 bp),
L-actin (300 bp), or LacZ (180 bp) were used for RT-PCR analysis of stable clones (panels A^H) using RNA isolated during growth (3DIFF)
or following di¡erentiation (+DIFF). -RT, samples prepared without reverse transcriptase. (I) PCR reactions using genomic DNA from C2C12,
cRP2044n5, cDY04n2 or mock reactions with no DNA to test primer function.
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provide an alternative binding site for the DRC complex,
thereby reducing the ability of this complex to silence its tar-
get genes. Indeed, such a squelching mechanism would be
enhanced with increasing repeat number. To test this model,
murine equivalents of the genes overexpressed in FSHD
muscle, such as ANT1 and FRG1, should be examined for
regulatory elements that interact with the DRC complex.
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